Last updated: May 18, 2026
What Epitalon is
Epitalon is a synthetic 4-amino-acid peptide with sequence Alanyl-Glutamyl-Aspartyl-Glycyl (Ala-Glu-Asp-Gly, AEDG). It’s a synthetic analog of an active component within epithalamin, the polypeptide extract from bovine pineal glands originally studied by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology.
Mechanism
Reported mechanisms from Khavinson research:
- Telomerase activation: Stimulates hTERT (human telomerase reverse transcriptase) expression in somatic cells
- Telomere length preservation: Slows or reverses telomere shortening with age
- Pineal-melatonin axis regulation: Normalizes circadian rhythm and melatonin pulsatility
- Anti-oxidant gene expression: Increases endogenous antioxidant systems
- Cell cycle modulation: Effects on p53 and other regulators
Khavinson human cohort studies
Published studies in elderly populations (300+ subjects, 12+ years follow-up):
- Reduced all-cause mortality by 20-30% vs control
- Improved sleep quality and circadian function
- Better metabolic parameters
- Preserved functional status
These studies use different methodologies than Western pharmaceutical RCTs but are substantial. Independent Western replication is limited.
Research dosing
Standard Khavinson protocol:
- 5-10 mg subcutaneous or intramuscular injection
- Daily for 10-20 days
- Repeat cycle 1-4 times per year
Pulse dosing (intermittent) rather than continuous use is a hallmark of Khavinson bioregulator protocols.
Sublingual / oral / nasal routes
Khavinson protocols also describe oral/sublingual application. Bioavailability is lower but the small tetrapeptide is reported to retain activity via these routes. Intranasal delivery has been studied for direct CNS access.
Effects expected
Based on Khavinson research:
- Improved sleep architecture (within 1-2 weeks)
- Subjective increase in energy and mood (within 2-4 weeks)
- Lab markers of inflammation may improve over months
- Telomere length: effects measured over 1-3 years in long-term studies
Safety profile
Notable safety in Khavinson research — no significant adverse events reported in cohorts of hundreds of elderly subjects. Theoretical concerns:
- Telomerase activation in cells with pre-cancerous changes could theoretically accelerate cancer
- Long-term effects in healthy young adults unstudied
- Effects in pediatric populations unstudied
Western evidence
Some Western research has replicated specific findings:
- Telomerase activation in cell culture confirmed
- Circadian effects observed
- Reduced markers of cellular senescence
However, large Western RCTs of Epitalon in elderly populations are not available.
Regulatory status
- Russia: Approved (Epithalamin original extract)
- US: Sold as research peptide; not FDA-approved
- Most other countries: Not approved for clinical use
Does Epitalon actually extend lifespan?<br />
Khavinson research in elderly cohorts shows reduced mortality. Western independent replication is limited. The mechanism (telomerase activation, circadian regulation) is plausible but extrapolation to lifespan extension in healthy adults is unproven.
How does Epitalon compare to other longevity peptides?<br />
Epitalon targets the pineal-melatonin axis and telomerase. MOTS-c targets mitochondrial function. Thymalin targets thymic-immune function. GHK-Cu targets tissue regeneration. They have complementary mechanisms.
Is the spelling “Epitalon” or “Epithalon”?<br />
Both are used. Russian transliteration produces both forms. The molecule is the same.
Can Epitalon be cycled long-term?<br />
Khavinson protocols use intermittent pulse dosing (10-20 days, 1-4x yearly) rather than continuous use. This pattern has been studied long-term in elderly cohorts.